Ieq Capital LLC Grows Position in Colgate-Palmolive (NYSE:CL)

Ieq Capital LLC boosted its position in shares of Colgate-Palmolive (NYSE:CL) by 22.6% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 38,617 shares of the company’s stock after buying an additional 7,130 shares during the quarter. Ieq Capital LLC’s holdings in Colgate-Palmolive were worth $3,747,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Vanguard Group Inc. grew its position in shares of Colgate-Palmolive by 0.5% in the 4th quarter. Vanguard Group Inc. now owns 79,894,344 shares of the company’s stock worth $6,368,378,000 after buying an additional 416,853 shares during the last quarter. Price T Rowe Associates Inc. MD increased its position in shares of Colgate-Palmolive by 27.8% during the first quarter. Price T Rowe Associates Inc. MD now owns 41,067,130 shares of the company’s stock valued at $3,698,096,000 after buying an additional 8,933,912 shares during the period. Massachusetts Financial Services Co. MA increased its position in shares of Colgate-Palmolive by 40.7% during the second quarter. Massachusetts Financial Services Co. MA now owns 8,969,498 shares of the company’s stock valued at $870,400,000 after buying an additional 2,593,313 shares during the period. GUARDCAP ASSET MANAGEMENT Ltd raised its stake in Colgate-Palmolive by 4.1% in the first quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 6,987,454 shares of the company’s stock worth $629,220,000 after buying an additional 278,150 shares in the last quarter. Finally, Acadian Asset Management LLC boosted its position in Colgate-Palmolive by 108.4% during the 2nd quarter. Acadian Asset Management LLC now owns 5,682,280 shares of the company’s stock valued at $551,367,000 after acquiring an additional 2,955,442 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of NYSE:CL opened at $103.06 on Friday. The company has a debt-to-equity ratio of 16.90, a quick ratio of 0.70 and a current ratio of 1.06. The firm has a market cap of $84.55 billion, a price-to-earnings ratio of 32.61, a price-to-earnings-growth ratio of 3.72 and a beta of 0.40. The business has a 50-day simple moving average of $102.71 and a two-hundred day simple moving average of $95.83. Colgate-Palmolive has a fifty-two week low of $67.62 and a fifty-two week high of $109.30.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The company had revenue of $5.06 billion for the quarter, compared to the consensus estimate of $5 billion. During the same quarter in the prior year, the firm earned $0.77 earnings per share. The firm’s revenue for the quarter was up 4.9% compared to the same quarter last year. On average, analysts expect that Colgate-Palmolive will post 3.57 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be issued a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 1.94%. The ex-dividend date is Friday, October 18th. Colgate-Palmolive’s payout ratio is currently 63.29%.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on CL. Evercore ISI raised their target price on Colgate-Palmolive from $100.00 to $106.00 and gave the company an “outperform” rating in a research note on Thursday, July 18th. Redburn Atlantic upgraded shares of Colgate-Palmolive to a “hold” rating in a report on Thursday, August 1st. Morgan Stanley increased their price target on shares of Colgate-Palmolive from $103.00 to $111.00 and gave the stock an “overweight” rating in a research note on Monday, July 29th. Stifel Nicolaus boosted their price objective on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the stock a “buy” rating in a research note on Monday, July 22nd. Finally, Deutsche Bank Aktiengesellschaft downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and raised their target price for the company from $107.00 to $109.00 in a research note on Monday, September 9th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat, Colgate-Palmolive has an average rating of “Moderate Buy” and an average target price of $102.79.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, insider Sally Massey sold 15,850 shares of the business’s stock in a transaction dated Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the completion of the sale, the insider now directly owns 13,942 shares in the company, valued at approximately $1,439,929.76. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In other news, insider Sally Massey sold 15,850 shares of the business’s stock in a transaction on Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the completion of the sale, the insider now owns 13,942 shares of the company’s stock, valued at approximately $1,439,929.76. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Martina Hundmejean sold 2,313 shares of the firm’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the transaction, the director now directly owns 11,755 shares in the company, valued at $1,220,874.30. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 43,490 shares of company stock worth $4,486,063. 0.34% of the stock is owned by insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.